[Federal Register Volume 60, Number 213 (Friday, November 3, 1995)]
[Notices]
[Pages 55846-55847]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-27322]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
International Cancer Information Center; Office of the Director;
National Cancer Institute; Journal
AGENCY: National Institutes of Health, PHS, DHHS.
ACTION: Advertisement.
-----------------------------------------------------------------------
Opportunity for a Cooperative Research and Development Agreement
(CRADA) for the development within the private sector of the capability
of producing a rapid turn-around multi-disciplinary cancer journal that
satisfies the need of the National Cancer Program for the dissemination
of high quality peer-reviewed, research that bears on the etiology,
biology, detection, prevention, and treatment of cancer. The journal
must also provide high quality scientific peer-reviewed articles,
reviews, editorials, commentaries and news.
SUMMARY: The International Cancer Information Center of the National
Cancer Institute, NIH is seeking a Collaborator with an international
reputation in the biomedical research and clinical practice
communities, as demonstrated by:
The quality of its information products, particularly its
biomedical journals;
Its commitment to the advancement of science and medical
practice, as evidenced by indicators of a high level of satisfaction by
health professionals with products and services, the range of products
and services offered, and the impact of its journal(s) as measured by
the Institute for Scientific Information (ISI) impact factors.
The Collaborator must be able to collaborate with NCI staff to
produce high quality information products. The Collaborator must have a
demonstrated record of success in privately producing biomedical and
clinical information resources.
The term of the CRADA will be five (5) years.
ADDRESSES: Inquiries and proposals regarding this opportunity should be
addressed to William Joseph Cotreau (Tel.# 301-496-0477, FAX# 301-402-
2117), Office of Technology Development, National Cancer Institute,
Building 31, Room 4A49, NIH, 9000 Rockville Pike, Bethesda, MD 20892.
DATES: Interested parties should notify this office in writing no later
than sixty (60) days from the date of this announcement in the Federal
Register. Respondents will then be given an additional sixty (60) days
for filing a formal proposal.
SUPPLEMENTARY INFORMATION: A Cooperative Research and Development
Agreement (CRADA) is the anticipated joint agreement to be entered into
by NCI pursuant to the Federal Technology Transfer Act of 1986 and
Executive Order 12591 of October 10, 1987. Under the present proposal,
the goal of the CRADA will be the development of the following
technology.
A rapid turn around multi disciplinary cancer journal (Journal of
the National Cancer Institute--JNCI) that satisfies the need of the
National Cancer Program for disseminating:
High quality scientific peer-reviewed research that bears
on the etiology, biology, detection, prevention, and treatment of
cancer
High quality scientific peer-reviewed articles, reviews,
editorials and commentaries
News
Electronic and new media cancer information sources.
All necessary existing rights and assets currently held by NCI for
the production of the JNCI will be licensed as needed to the
Collaborator.
The Journal produced under the CRADA will operate in conformance
with the Guidelines of the International Committee of Biomedical
Journal Editors among other guidelines. These guidelines establish the
editorial freedom of the editor-in-chief and maintain the integrity of
the Journal. Editorial control and overall intellectual oversight will
therefore be the province of the editor-in-chief. The editor-in-chief
will be appointed by the NCI and approved by the Collaborator. NCI and
Collaborator staff will contribute to achieving the intellectual goals
determined by the editor-in-chief. The Collaborator will also
contribute the business and marketing expertise and the technical,
management, and R&D expertise required for the maintenance and
dissemination of a derivative electronic journal or information
product.
Party Contributions
The role of the NCI includes the following:
(1) Cooperate with Collaborator to jointly produce the Journal of
the National Cancer Institute and related information products;
(2) Provide the Editor-in-Chief for the JNCI and related
information products;
(3) Provide all line staff functions for the publication of the
JNCI and related information products until the Collaborator is able to
provide the same to the satisfaction of the Editor-in-Chief, including
assistance with maintainence of the mailing list;
(4) Evaluate the work product of Collaborator to ensure progress
toward meeting the CRADA goals;
(5) Provide work space and equipment for production of the JNCI and
related information products until the Collaborator is able to provide
the same to the satisfaction of the Editor-in-Chief.
The role of the successful Collaborator will include the following:
(1) Transition to independently produce the JNCI and related
information products;
(2) Provide funding, as necessary, in support of production and
dissemination of information products;
(3) Provide expertise in production and marketing of biomedical
information products;
(4) Provide resources to market biomedical information products;
(5) Cooperate with Editor-in-Chief in all aspects of meeting
information needs of the National Cancer Program;
(6) Invoice accounts and receive, process, and disburse funds for
NCI;
(7) Maintain mailing list electronically in a database of the NCI's
choice.
Selection Criteria
Proposals submitted for consideration should fully address each of
the following qualifications:
1. Expertise:
A. Demonstrated expertise in developing and producing high quality
biomedical print journals (and spin off print and electronic biomedical
information products);
B. Demonstrated expertise in overseeing all aspects of product
development;
C. Demonstrated intellectual ability to guide development of
product line which addresses the requirements of the National Cancer
Program;
D. Demonstrated expertise in conducting rapid peer and editorial
review of biomedical information products;
E. Demonstrated expertise in techniques of fast production of
publications and information materials;
F. Demonstrated expertise in marketing of biomedical information
products;
G. Demonstrated expertise in subscription management, advertising,
fulfilment and customer service;
H. Knowledge of basic and clinical research, including but not
limited to:
[[Page 55847]]
Research in the biology, treatment, detection, and prevention of
disease;
I. Experience in publishing biomedical research;
J. Demonstrated proficiency in serving a large membership base.
2. Reputation:
The successful Collaborator must be recognized in the biomedical
research and clinical practice communities for:
A. The quality of its information products, particularly its
biomedical journals;
B. Its commitment to the advancement of science and medical
practice;
C. Indications of high levels of satisfaction by health
professionals with the information products and services;
D. The range of products and services;
E. The impact of its journal(s) as measured by the Institute for
Scientific Information (ISI).
3. Physical Resources:
A. An established headquarters with offices, space and equipment;
B. Personal access to the organization during business hours;
C. Access to the organization during business hours by telephone,
mail, e-mail, the Internet and other evolving technologies;
D. Sufficient financial resources to support, at a minimum, the
current activities of the JNCI to meet the needs of the National Cancer
Program.
Dated: October 26, 1995.
Thomas Mays,
Director, Office of Technology Development, National Cancer Institute,
National Institutes of Health.
[FR Doc. 95-27322 Filed 11-2-95; 8:45 am]
BILLING CODE 4140-01-P
